HRS4R
Vull donar
Firma
ARANTXA ERASO-URIÉN
Posició
Cap de Grup - R4
Caps de Grup - R4

Projectes

Codi oficial: Estudio PREV Data inici: 01/11/2021 Data fi: 31/12/2025 Investigador/a principal: ARANTXA ERASO URIÉN, SERGI MORAL TORRES Organisme finançador: FUNDACION MERCK SALUD
Codi oficial: ADARNAT I Data inici: 09/12/2022 Data fi: 09/12/2027 Investigador/a principal: LUIS MIGUEL ALONSO RUANO, ARANTXA ERASO URIÉN Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER
Codi oficial: 2021 SGR 01463 - ONCORFIM Girona Data inici: 01/01/2022 Data fi: 30/06/2025 Investigador/a principal: ARANTXA ERASO URIÉN Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER.

Publicacions

Marruecos Querol J, Jurado-Bruggeman D, Lopez-Vidal A, Mesía Nin R, Rubió-Casadevall J, Buxó M, Eraso Urien A

Contouring aid tools in radiotherapy. Smoothing: the false friend.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2024 dx.doi.org/10.1007/s12094-024-03420-9
Marruecos-Querol J, Rubió-Casadevall J, Lozano A, Buxó M, Puigdemont M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Borés A, Recalde S, Saigi M, Felip E, Eraso A, Mesía R

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 2384-2392 dx.doi.org/10.1007/s12094-023-03121-9
Auñón C, Sanvisens A, Turon E, Vidal-Vila A, Puigdemont M, Osca-Gelis G, Eraso A, Marcos-Gragera R

Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).

CANCER MEDICINE, 2023, 12, 12343-12353 dx.doi.org/10.1002/cam4.5935
Pardo García R, Piñero Madrona A, Algara López M, Bernet Vegué L, Eraso Urien A

Just medical oncology guidelines….

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 3319-3320 dx.doi.org/10.1007/s12094-023-03272-9
Coma N, Resta H, Moral S, Eraso MA, Ventura M, Brugada R

Uncommon short- and long-term cardiological side effects of thoracic radiation: a report of two cases.

Future Cardiology, 2023, 19, 529-535 dx.doi.org/10.2217/fca-2023-0027
Sanz J, Eraso A, Ibáñez R, Williams R, Algara M

Tumor Bed Boost Radiotherapy in the Conservative Treatment of Breast Cancer: A Review of Intra-Operative Techniques and Outcomes.

Cancers, 2023, 15 dx.doi.org/10.3390/cancers15164025
Laplana, M, Garcia-Marqueta, M, Sanchez-Fernandez, JJ, Martinez-Perez, E, Perez-Montero, H, Martinez-Montesinos, I, Eraso, A, Saldana, P, Martin, R, Martin, MI, Pla, MJ, Garcia-Tejedor, A, Guedea, F

Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM(R)) for accelerated partial breast irradiation (APBI)

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 1732-1743 dx.doi.org/10.1007/s12094-022-02823-w
Eraso A, Sanz J, Mollà M, Reyes V, Pedro A, Arenas M, Martinez E, Ballester R, Cambra MJ, García V, Prades JL, Borras JM, Algara M

Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 1580-1587 dx.doi.org/10.1007/s12094-022-02798-8
Locquet, M, Spoor, D, Crijns, A, van der Harst, P, Eraso, A, Guedea, F, Fiuza, M, Santos, SCR, Combs, S, Borm, K, Mousseaux, E, Gencer, U, Frija, G, Cardis, E, Langendijk, H, Jacob, S

Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY-HEART study)

Frontiers in oncology, 2022, 12, 883679-883679 dx.doi.org/10.3389/fonc.2022.883679
Zamora V, Garin O, Pardo Y, Pont À, Gutiérrez C, Cabrera P, Gómez-Veiga F, Pijoan JI, Litwin MS, Ferrer M, Multicentric Spanish Group of Clinically Localized Prostate Cancer

Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys

VALUE IN HEALTH, 2021, 24, 1676-1685 dx.doi.org/10.1016/j.jval.2021.03.021

Formulari de contacte

Coneix l’IDIBGI!

menu